Framework for Equitable Allocation of COVID-19 Vaccine
By: Benjamin Kahn, Lisa Brown, William Foege, and Helene Gayle
Source: National Academies of Sciences, Engineering, and Medicine
Approval, allocation, and distribution of one or more safe and effective coronavirus disease 2019 (COVID-19) vaccines will be a remarkable achievement. However, as has been pointed out repeatedly since the earliest days of the COVID-19 pandemic, readying a vaccine is just the starting point of what will be a challenging journey to achieving widespread public acceptance of COVID-19 vaccines. Strong demand for and acceptance of COVID-19 vaccines will be critical for protecting vulnerable populations and for regaining our pre-pandemic social and economic lives, but ensuring demand and promoting acceptance will be challenging.
Health for All Ages: Life-course immunization
The benefits of a life-course immunization approach for reaching zero dose-adults, children, and promoting vaccine equity worldwide.
World Refugee Day 2022 Q & A with Silas Ayako
Silas Ayako, Project Clinical Officer, Protection of Refugees and Asylum Seekers at Kenya Red Cross, joins us for a World Refugee Day Q & A.
VARN2022 Conference Report
Findings and insights from the Sabin Vaccine Institute’s inaugural VARN conference